Welcome to LookChem.com Sign In|Join Free

CAS

  • or

42293-72-1

Post Buying Request

42293-72-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

42293-72-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 42293-72-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,2,9 and 3 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 42293-72:
(7*4)+(6*2)+(5*2)+(4*9)+(3*3)+(2*7)+(1*2)=111
111 % 10 = 1
So 42293-72-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H19NO4S/c1-10(14(18)12-6-4-3-5-7-12)8-21-9-13(15(19)20)16-11(2)17/h3-7,10,13H,8-9H2,1-2H3,(H,16,17)(H,19,20)

42293-72-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Acetyl-S-(2-methyl-3-oxo-3-phenylpropyl)cysteine

1.2 Other means of identification

Product number -
Other names Benazepril [INN:BAN]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:42293-72-1 SDS

42293-72-1Upstream product

42293-72-1Downstream Products

42293-72-1Relevant articles and documents

Substituted cysteines

-

, (2008/06/13)

This invention relates to a new group of substituted cysteines having the general formula: STR1 in which: Ar is an aromatic or heteromonocyclic group, such as 2-thienyl or phenyl, which may be substituted by a halogen atom or by a lower alkyl or alkoxy group, and R is a hydrogen atom or a lower alkyl group. These compounds are of use in human therapeutics as liquifiers for bronchal secretions in complaints of the respiratory passage and, in particular, in chronic bronchitis. The invention also relates to a method of preparing these compounds and to the application of these compounds, particularly in human therapeutics.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 42293-72-1